Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 2 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with psoriasis will develop ...
Which Vitamins Are Good For Arthritis?
Shape via Yahoo News· 4 days agoGeorgiy Brusovanik, MD, an orthopedist and minimally invasive spine surgeon, says there are two main types of arthritis: inflammatory and...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 6 hours agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 2 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 8 hours agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
I Created a Community For the Chronically Ill. I Didn't Expect It to Save My Life.
PopSugar· 2 days agoOver two decades later, I used my lifetime of experience to build Chronicon, a community and...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
FOX 59 Indianapolis· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 1 day agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
Hundreds participate in ‘Walk to Cure Arthritis’ to help find a cure
WJXT Jacksonville· 6 days agoHundreds of people walked together Saturday at the Jacksonville Arboretum and Botanical Gardens to...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 2 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.